# French Lavender (Lavandula angustifolia 'French')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/french-lavender
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Lavandula angustifolia 'French', French Lavender cultivar, French True Lavender, Lavande de France, French English Lavender, L. angustifolia French variety, French Lavandula angustifolia

## Overview

French Lavender (Lavandula angustifolia 'French') contains linalool and linalyl acetate as primary bioactive terpenes, which drive its antioxidant and [antimicrobial](/ingredients/condition/immune-support) properties through [free radical scaveng](/ingredients/condition/antioxidant)ing and membrane disruption mechanisms. Current evidence is confined to laboratory assays, with no human clinical trials published to substantiate therapeutic claims.

## Health Benefits

• [Antioxidant activity](/ingredients/condition/antioxidant) demonstrated in DPPH and ABTS assays (preliminary in vitro evidence only)
• Antibacterial effects against Gram-positive bacteria (preliminary in vitro evidence only)
• Ferric reducing power shown in laboratory tests (preliminary in vitro evidence only)
• No human clinical trials available for this specific cultivar
• Evidence limited to chemical composition studies and in vitro assays

## Mechanism of Action

Linalool and linalyl acetate, the dominant monoterpenes in French Lavender essential oil, neutralize free radicals by donating hydrogen atoms to DPPH and ABTS radical species, reducing [oxidative stress](/ingredients/condition/antioxidant) markers in cell-free assays. Antibacterial activity against Gram-positive organisms such as Staphylococcus aureus is attributed to terpene-mediated disruption of lipid bilayer integrity, increasing membrane permeability and causing leakage of intracellular contents. Ferric reducing antioxidant power (FRAP) activity reflects the polyphenolic constituents, including rosmarinic acid and luteolin, which chelate transition metal ions and interrupt Fenton-type oxidative chain reactions.

## Clinical Summary

All current evidence for French Lavender's [antioxidant](/ingredients/condition/antioxidant) and antibacterial properties derives from in vitro laboratory models, including DPPH radical scavenging assays, ABTS decolorization tests, and broth microdilution [antimicrobial](/ingredients/condition/immune-support) testing, none of which involve human subjects. No randomized controlled trials, observational cohort studies, or pilot clinical investigations have been conducted specifically on this Lavandula angustifolia cultivar. While related lavender species and preparations have been studied in small human trials for anxiety and sleep (e.g., the oral lavender oil product Silexan at 80 mg/day in trials of 50–200 participants), those findings cannot be directly extrapolated to French Lavender as a distinct cultivar. The overall evidence base is preliminary, and efficacy or safety in humans remains unestablished.

## Nutritional Profile

Macronutrients (per 100g dried herb, estimated from Lavandula angustifolia compositional data): Carbohydrates ~40-50g (primarily cellulose, hemicellulose, and pectin-based structural polysaccharides); Dietary fiber ~25-30g; Protein ~5-7g (limited essential amino acid profile); Fat ~3-5g (including small amounts of linoleic acid and alpha-linolenic acid). Moisture content in fresh material ~60-70%. Micronutrients: Calcium ~1,000-1,500mg/100g dried (notably high due to cell wall mineral binding); Iron ~10-15mg/100g dried; Potassium ~400-600mg/100g dried; Magnesium ~50-80mg/100g dried; Manganese ~3-5mg/100g dried. Vitamins: Vitamin C (ascorbic acid) ~50-100mg/100g fresh (degrades significantly on drying); small amounts of Vitamin A precursors (carotenoids including beta-carotene, ~1-3mg/100g dried). Bioactive compounds: Linalool (primary volatile terpene, ~20-45% of essential oil fraction); Linalyl acetate (~25-45% of essential oil fraction); 1,8-Cineole (~3-10%); Camphor (~0.5-4%); Beta-ocimene (~2-5%); Terpinen-4-ol (~2-6%); Rosmarinic acid (phenolic acid, ~5-20mg/g dried herb, primary [antioxidant](/ingredients/condition/antioxidant) contributor); Luteolin and luteolin glycosides (~1-5mg/g dried); Apigenin (~0.5-2mg/g dried); Coumarin (~0.3-1mg/g dried, warrants caution at high doses); Chlorogenic acid (trace to ~2mg/g dried). Essential oil yield for 'French' cultivar: approximately 0.8-1.5% of dried plant material by steam distillation. Bioavailability notes: Linalool and linalool acetate are highly bioavailable via inhalation and transdermal absorption but oral bioavailability is variable due to first-pass [metabolism](/ingredients/condition/weight-management); rosmarinic acid shows moderate oral bioavailability (~15-30%); mineral content (Ca, Fe) has reduced bioavailability due to binding with oxalic acid and tannin-like polyphenols present in the matrix; culinary use quantities (typically <1-2g per serving) mean micronutrient contributions are nutritionally negligible in practical dietary contexts.

## Dosage & Preparation

No clinically studied dosage ranges are available for French Lavender extracts, powders, or standardized forms as human trials have not been reported. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Topical application of French Lavender essential oil can cause contact dermatitis or allergic sensitization, particularly with oxidized linalool and linalyl acetate formed upon air exposure; patch testing is recommended before widespread dermal use. Oral ingestion of lavender essential oils is not generally considered safe in undiluted form and may cause nausea, vomiting, or central nervous system depression at higher doses. French Lavender may theoretically potentiate sedative medications including benzodiazepines, barbiturates, and other CNS depressants due to linalool's reported GABAergic activity observed in animal models, warranting caution with concurrent use. Safety during pregnancy and lactation has not been established for this cultivar specifically, and use beyond culinary amounts should be avoided in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found for the French cultivar of Lavandula angustifolia. Available research focuses exclusively on chemical composition analysis and in vitro biological effects such as [antioxidant](/ingredients/condition/antioxidant) and antibacterial activity, with no PubMed PMIDs provided for human studies.

## Historical & Cultural Context

Traditional or historical medicinal uses are not documented in the available research. Current studies focus exclusively on modern chemical analysis rather than ethnobotanical context.

## Synergistic Combinations

Other lavender varieties, chamomile, valerian, lemon balm, passionflower

## Frequently Asked Questions

### What is French Lavender used for in supplements?

French Lavender is primarily referenced for its antioxidant and antibacterial properties based on in vitro data showing linalool and linalyl acetate scavenge DPPH and ABTS free radicals and inhibit Gram-positive bacteria. No human clinical trials have validated these uses as supplement health claims, so marketed benefits remain speculative beyond laboratory findings.

### What are the active compounds in French Lavender?

The principal bioactive compounds in French Lavender (Lavandula angustifolia 'French') are the monoterpenes linalool and linalyl acetate, which together typically constitute 60–80% of the essential oil fraction. Secondary polyphenols including rosmarinic acid, luteolin, and ursolic acid also contribute to measured antioxidant activity in FRAP assays.

### Is French Lavender the same as regular lavender?

French Lavender refers to a specific cultivar selection of Lavandula angustifolia, sharing the same species as common English lavender but potentially differing in terpene chemotype ratios, linalool content, and polyphenol concentration depending on growing conditions and extraction method. These cultivar-level differences mean research conducted on generic Lavandula angustifolia extracts or the Silexan preparation cannot be directly applied to French Lavender without cultivar-specific testing.

### Does French Lavender have any proven benefits in humans?

As of available published literature, there are no human clinical trials specifically investigating French Lavender (Lavandula angustifolia 'French'), meaning no proven benefits in humans can be cited for this cultivar. Antioxidant and antibacterial findings are limited to cell-free and in vitro bacterial culture models, which do not reliably predict clinical outcomes in living organisms.

### Can French Lavender interact with any medications?

French Lavender's primary terpene linalool has demonstrated GABAergic modulation in rodent studies, suggesting a theoretical risk of enhanced sedation when combined with benzodiazepines, sleep aids, anticonvulsants, or opioids. Additionally, lavender polyphenols such as rosmarinic acid may weakly inhibit CYP450 enzymes in vitro, raising a speculative concern about altered metabolism of drugs processed by CYP1A2 or CYP3A4, though no human pharmacokinetic studies confirm this interaction for this cultivar.

### What is the current state of clinical research on French Lavender (Lavandula angustifolia 'French')?

Clinical research on this specific French Lavender cultivar is extremely limited, with no human clinical trials currently available. Most evidence comes from preliminary in vitro laboratory studies examining chemical composition, antioxidant activity in DPPH and ABTS assays, and antibacterial effects against Gram-positive bacteria. These laboratory findings cannot be directly applied to human health outcomes without proper clinical validation. Consumers should be aware that supplement claims based on this cultivar lack the robust human trial evidence needed to confirm efficacy.

### How does French Lavender cultivar differ from other lavender varieties in terms of supplement effectiveness?

The French Lavender cultivar (Lavandula angustifolia 'French') has not been directly compared to other lavender varieties in human studies, making definitive effectiveness claims impossible. While some general lavender species have more established research, this specific cultivar's unique chemical profile and in vitro antioxidant properties have not been validated in clinical settings. Without comparative human trials, it is unclear whether this cultivar offers meaningful advantages over standard lavender or other botanical alternatives. Choosing between lavender cultivars should not be based on cultivar name alone, as marketing distinctions often exceed scientific substantiation.

### What populations should be cautious about using French Lavender supplements given the limited research?

Due to the absence of human clinical trials on this specific cultivar, caution is warranted for pregnant and nursing women, children, elderly individuals with multiple medications, and those with known lavender sensitivities. People taking sedatives, blood thinners, or medications metabolized by the liver should consult healthcare providers before use, as in vitro data cannot predict real-world interaction risks. The preliminary nature of available evidence means individual responses are unpredictable, making medical supervision especially important for vulnerable populations. Without human safety data, personalizing use based on individual health status is strongly recommended.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*